SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYBR CyberCare the new look of healthcare
CYBR 453.650.0%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sommovigo who wrote (1936)5/24/2000 2:45:00 PM
From: StockDung  Read Replies (2) of 3392
 
"Specifically, the complaint alleges that the defendants failed to disclose that since Cyber-Care's much-hyped Electronic Housecall System, or "EHS" had not yet received FDA approval, it could not be sold or marketed in any way, and that to the extent Cyber-Care was announcing sales or agreements to buy, Cyber-Care was in violation of governmental regulations. In addition, the complaint alleges that as for the sales and agreements Cyber-Care did announce, many were to entities that were either so unestablished or in such poor financial condition as to make the likelihood of the sales actually occurring extremely small. Also undisclosed was that a purported independent analyst touting the stock was actually employed by Cyber-Care's PR firm."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext